192 related articles for article (PubMed ID: 2555704)
1. Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro.
Boulukos KE; Pognonec P; Rabault B; Begue A; Ghysdael J
Mol Cell Biol; 1989 Dec; 9(12):5718-21. PubMed ID: 2555704
[TBL] [Abstract][Full Text] [Related]
2. The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1.
Bosselut R; Duvall JF; Gégonne A; Bailly M; Hémar A; Brady J; Ghysdael J
EMBO J; 1990 Oct; 9(10):3137-44. PubMed ID: 2209540
[TBL] [Abstract][Full Text] [Related]
3. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1.
Bhat NK; Thompson CB; Lindsten T; June CH; Fujiwara S; Koizumi S; Fisher RJ; Papas TS
Proc Natl Acad Sci U S A; 1990 May; 87(10):3723-7. PubMed ID: 2187191
[TBL] [Abstract][Full Text] [Related]
5. Sequence-specific interaction of the Ets1 protein with the long terminal repeat of the human T-lymphotropic virus type I.
Gitlin SD; Bosselut R; Gégonne A; Ghysdael J; Brady JN
J Virol; 1991 Oct; 65(10):5513-23. PubMed ID: 1895400
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
7. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2.
Yang BS; Hauser CA; Henkel G; Colman MS; Van Beveren C; Stacey KJ; Hume DA; Maki RA; Ostrowski MC
Mol Cell Biol; 1996 Feb; 16(2):538-47. PubMed ID: 8552081
[TBL] [Abstract][Full Text] [Related]
8. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
Hagman J; Grosschedl R
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Ets1 variant protein unaffected in its chromatin and in vitro DNA binding capacities by T cell antigen receptor triggering and intracellular calcium rises.
Pognonec P; Boulukos KE; Bosselut R; Boyer C; Schmitt-Verhulst AM; Ghysdael J
Oncogene; 1990 Apr; 5(4):603-10. PubMed ID: 2183162
[TBL] [Abstract][Full Text] [Related]
10. Localization and modulation of the DNA-binding activity of the human c-ets-1 protooncogene.
Reddy ES; Rao VN
Cancer Res; 1990 Aug; 50(16):5013-6. PubMed ID: 2165853
[TBL] [Abstract][Full Text] [Related]
11. EAPII interacts with ETS1 and modulates its transcriptional function.
Pei H; Yordy JS; Leng Q; Zhao Q; Watson DK; Li R
Oncogene; 2003 May; 22(18):2699-709. PubMed ID: 12743594
[TBL] [Abstract][Full Text] [Related]
12. The highly conserved beta-hairpin of the paired DNA-binding domain is required for assembly of Pax-Ets ternary complexes.
Wheat W; Fitzsimmons D; Lennox H; Krautkramer SR; Gentile LN; McIntosh LP; Hagman J
Mol Cell Biol; 1999 Mar; 19(3):2231-41. PubMed ID: 10022910
[TBL] [Abstract][Full Text] [Related]
13. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
Cheng YH; Handwerger S
J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
[TBL] [Abstract][Full Text] [Related]
14. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
15. Ets-1 flips for new partner Pax-5.
Pufall MA; Graves BJ
Structure; 2002 Jan; 10(1):11-4. PubMed ID: 11796106
[TBL] [Abstract][Full Text] [Related]
16. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
[TBL] [Abstract][Full Text] [Related]
17. The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner.
Basuyaux JP; Ferreira E; Stéhelin D; Butticè G
J Biol Chem; 1997 Oct; 272(42):26188-95. PubMed ID: 9334186
[TBL] [Abstract][Full Text] [Related]
18. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
19. Ets1, when fused to the GAL4 DNA binding domain, efficiently enhances galactose promotor dependent gene expression in yeast.
Seneca S; Punyammalee B; Bailly M; Ghysdael J; Crabeel M
Oncogene; 1991 Mar; 6(3):357-60. PubMed ID: 1901401
[TBL] [Abstract][Full Text] [Related]
20. Importance of ets1 proto-oncogene for breast cancer progression.
Dittmer J; Vetter M; Blumenthal SG; Lindemann RK; Kölbl H
Zentralbl Gynakol; 2004 Aug; 126(4):269-71. PubMed ID: 15389378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
